Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jill, Hagenkord"'
Autor:
Robert G. Best, George Khushf, Sara Schonfeld Rabin-Havt, Ellen Wright Clayton, Theresa A. Grebe, Jill Hagenkord, Scott Topper, Jaime Fivecoat, Margaret Chen, Wayne W. Grody
Publikováno v:
Genetics in medicine : official journal of the American College of Medical Genetics. 24(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f184146bd73e2974b11c8363e52a0db
https://pubmed.ncbi.nlm.nih.gov/35253644
https://pubmed.ncbi.nlm.nih.gov/35253644
Autor:
Jill Hagenkord, Birgit Funke, Emily Qian, Madhuri Hegde, Kevin B Jacobs, Matthew Ferber, Matthew Lebo, Adam H Buchanan, David Bick
As the cost of DNA sequencing continues to fall, more individuals are opting to undergo genomic testing in the absence of a clinical indication. Testing asymptomatic individuals for unsuspected conditions is not new to the medical and public health c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::032135bebe587a2b1db4c7aad81b6698
Autor:
Angela R. Bradbury, Stephanie M. Fullerton, Debra G.B. Leonard, Theodore G. Ganiats, George Isham, Kimberly A. Kaphingst, Catherine Wicklund, James P. Evans, Marissa Levine, Catharine Wang, Ellen Matloff, Leonard W. Ortmann, Debra Lochner Doyle, Nazneen Aziz, Michael F. Murray, Misha Angrist, Kristen Young, Muin J. Khoury, Wendy R. Uhlmann, W. David Dotson, Joan Scott, Sun Hee Rim, Sara Imhof, Jill Hagenkord, Ann G. Zauber, Bruce R. Korf
Publikováno v:
NAM Perspectives.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19b89039a44dd7ce06629445f389cd88
https://doi.org/10.31478/201812a
https://doi.org/10.31478/201812a
Autor:
James T, Lu, Matthew, Ferber, Jill, Hagenkord, Elissa, Levin, Sarah, South, Hyunseok P, Kang, Kimberly A, Strong, David P, Bick
Publikováno v:
The Journal of molecular diagnostics : JMD. 21(1)
The increasing quality and diminishing cost of next-generation sequencing has transformed our ability to interrogate large quantities of genetic information. This has led to a dramatic increase in the number of elective genomic tests performed. In th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1fcf4a452f1d6513238d26935baa38a3
https://pubmed.ncbi.nlm.nih.gov/30577885
https://pubmed.ncbi.nlm.nih.gov/30577885
Autor:
Loren, Joseph, Milena, Cankovic, Samuel, Caughron, Pranil, Chandra, Rajyasree, Emmadi, Jill, Hagenkord, Stephanie, Hallam, Kay E, Jewell, Roger D, Klein, Victoria M, Pratt, Paul G, Rothberg, Robyn L, Temple-Smolkin, Elaine, Lyon
Publikováno v:
The Journal of molecular diagnostics : JMD. 18(5)
Clinical utility describes the benefits of each laboratory test for that patient. Many stakeholders have adopted narrow definitions for the clinical utility of molecular testing as applied to targeted pharmacotherapy in oncology, regardless of the po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::142e91789e465284c9fa33f0d3f76614
https://pubmed.ncbi.nlm.nih.gov/27542512
https://pubmed.ncbi.nlm.nih.gov/27542512